These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 9365830)
1. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830 [TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
3. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612 [TBL] [Abstract][Full Text] [Related]
4. Allele loss on chromosome 1p36 in epithelial ovarian cancers. Alvarez AA; Lambers AR; Lancaster JM; Maxwell GL; Ali S; Gumbs C; Berchuck A; Futreal PA Gynecol Oncol; 2001 Jul; 82(1):94-8. PubMed ID: 11426968 [TBL] [Abstract][Full Text] [Related]
5. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846 [TBL] [Abstract][Full Text] [Related]
6. Clonal origin of lymph node metastases in bladder carcinoma. Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast. Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258 [TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients]. Zhang H; Li Z; Chen M; Zhang G; Xu K Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406 [TBL] [Abstract][Full Text] [Related]
9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study. Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342 [TBL] [Abstract][Full Text] [Related]
11. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522 [TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma. Cheung TH; Chung TK; Poon CS; Hampton GM; Wang VW; Wong YF Cancer; 1999 Oct; 86(7):1294-8. PubMed ID: 10506716 [TBL] [Abstract][Full Text] [Related]
13. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis]. Xu XF; Tang PZ; Cheng SJ Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701 [TBL] [Abstract][Full Text] [Related]
14. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108 [TBL] [Abstract][Full Text] [Related]
15. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351 [TBL] [Abstract][Full Text] [Related]
17. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Edelson MI; Lau CC; Colitti CV; Welch WR; Bell DA; Berkowitz RS; Mok SC Oncogene; 1998 Jan; 16(2):197-202. PubMed ID: 9464537 [TBL] [Abstract][Full Text] [Related]
18. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]. Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas. Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046 [TBL] [Abstract][Full Text] [Related]
20. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Davis M; Hitchcock A; Foulkes WD; Campbell IG Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]